Alkeon Capital Management
PMVP icon

Alkeon Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Alkeon Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,342,373
Closed -$2.48M – 114
2025
Q2 		$2.48M Hold
2,342,373
– – ﹤0.01% 102
2025
Q1 		$2.55M Sell
2,342,373
-1,358
-0.1% -$1.84K 0.01% 104
2024
Q4 		$3.54M Hold
2,343,731
– – 0.01% 92
2024
Q3 		$3.49M Sell
2,343,731
-1,630
-0.1% -$2.52K 0.01% 94
2024
Q2 		$3.8M Hold
2,345,361
– – 0.01% 98
2024
Q1 		$3.99M Hold
2,345,361
– – 0.01% 97
2023
Q4 		$7.27M Sell
2,345,361
-2,053
-0.1% -$5.43K 0.02% 91
2023
Q3 		$14.4M Buy
2,347,414
+867,547
+59% +$5.96M 0.03% 90
2023
Q2 		$9.26M Buy
1,479,867
+98,538
+7% +$516K 0.02% 106
2023
Q1 		$6.59M Sell
1,381,329
-3,938
-0.3% -$27.7K 0.01% 118
2022
Q4 		$12.1M Sell
1,385,267
-131,979
-9% -$1.41M 0.05% 113
2022
Q3 		$18.1M Sell
1,517,246
-2,689
-0.2% -$38.8K 0.06% 115
2022
Q2 		$21.7M Sell
1,519,935
-79,618
-5% -$1.16M 0.06% 114
2022
Q1 		$33.3M Hold
1,599,553
– – 0.07% 118
2021
Q4 		$36.9M Buy
1,599,553
+180,000
+13% +$4.35M 0.07% 113
2021
Q3 		$42.3M Buy
1,419,553
+292,135
+26% +$9.33M 0.07% 121
2021
Q2 		$38.5M Sell
1,127,418
-2,263
-0.2% -$75.6K 0.06% 124
2021
Q1 		$37.2M Buy
1,129,681
+2,530
+0.2% +$99.7K 0.06% 121
2020
Q4 		$69.3M Buy
1,127,151
+652,151
+137% +$25.6M 0.11% 108
2020
Q3 		$16.9M Buy
+475,000
New +$17.5M 0.03% 124

Other funds holding PMVP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alkeon Capital Management's PMVP Position: Q3 2025 in Review

Alkeon Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q3 2025, closing a stake of 2,342,373 shares — an estimated $2.48M sold.

Alkeon Capital Management first reported a position in PMVP in Q3 2020 and held it in 20 quarters. The position peaked at $69.3M in Q4 2020. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • Alkeon Capital Management reported no remaining PMV Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Alkeon Capital Management sold 2,342,373 PMV Pharmaceuticals shares in Q3 2025, an estimated $2.48M.
  • Alkeon Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 20 quarters.
  • Alkeon Capital Management's PMV Pharmaceuticals position peaked at $69.3M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on Alkeon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.